‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy

Karen Bonham was part of successful trial for genomic test that determines which women with breast cancer can safely avoid chemotherapy

• Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

A landmark study shows millions of women with breast cancer could skip chemotherapy thanks to a genomic test that determines who needs the treatment and who doesn’t.

The randomised international trial specifically looked at whether the test could identify those patients who would not benefit from chemotherapy, and then see if they could safely avoid it.